Susquehanna International Group, LLP Pharma Cyte Biotech, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 16, 2023
BUY
$2.83 - $3.03 $8,490 - $9,090
3,000 Added 8.13%
39,900 $116,000
Q4 2022

Feb 14, 2023
SELL
$2.39 - $3.07 $85,801 - $110,213
-35,900 Reduced 49.31%
36,900 $108,000
Q3 2022

Nov 14, 2022
SELL
$2.24 - $2.85 $180,096 - $229,140
-80,400 Reduced 52.48%
72,800 $175,000

Others Institutions Holding PMCB

# of Institutions
30
Shares Held
932K
Call Options Held
0
Put Options Held
0
View Full List

About PharmaCyte Biotech, Inc.

PMCB Quotes by TradingView
  • Ticker PMCB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,750,100
  • Market Cap $33.2M
  • Description
  • PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...
More about PMCB
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email